Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | HTT | P42858 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | USP2 | O75604 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | FTO | Q9C0B1 | 9/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL329253 | 1.00 | GSTP1 (1.00) | GSTP1MAPTMEN1KMT2AHTT | |
| SCHEMBL4204743 | 0.84 | GSTP1 (0.73) | GSTP1MAPTMEN1KMT2AHTT | |
| SCHEMBL20353147 | 0.84 | MAPT (0.78) | GSTP1MAPTMEN1KMT2AHTT | |
| Fluorescein Diacetate SCHEMBL29453229 | 0.84 | MAPT (1.00) | GSTP1MAPTMEN1KMT2AHTT | |
| Fluorescein Diacetate SCHEMBL29353816 | 0.84 | MAPT (1.00) | GSTP1MAPTMEN1KMT2AHTT | |
| Fluorescein Diacetate SCHEMBL1028369 | 0.84 | MAPT (1.00) | GSTP1MAPTMEN1KMT2AHTT | |
| Fluorescein Diacetate SCHEMBL31658971 | 0.84 | MAPT (1.00) | GSTP1MAPTMEN1KMT2AHTT | |
| SCHEMBL29403728 | 0.83 | MEN1 (0.77) | GSTP1MAPTMEN1KMT2AHTT | |
| SCHEMBL18677730 | 0.83 | MAPT (0.77) | GSTP1MAPTMEN1KMT2AHTT | |
| SCHEMBL12639984 | 0.83 | MEN1 (0.77) | GSTP1MAPTMEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118995568-A | Construction method and application of cholestasis organ model | 北京清华长庚医院 | 2024-11-22 | — | — | CN | claimed |
| US-20240151731-A1 | MEMBRANE PROTEIN INTERACTION SCREENING PLATFORM BASED ON CELL-CELL ADHESION EFFECTS | SUZHOU INSTITUTE OF SYSTEMS MEDICINE (CN) | 2024-05-09 | — | — | US | claimed |
| CN-117625727-A | Evaluation method for in-vitro killing of tumor-infiltrating lymphocytes | 北京臻知医学科技有限责任公司 | 2024-03-01 | — | — | CN | claimed |
| CN-114134198-B | Reagent, device and method for rapid counting of eukaryotic microorganisms | 国家粮食和物资储备局科学研究院 | 2024-01-26 | — | — | CN | claimed |
| US-20230341377-A1 | DISCONNECTION AGENTS | DC EUROPA LIMITED (GB) | 2023-10-26 | — | — | US | claimed |
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| EP-4214505-A1 | DISCONNECTION AGENTS | DC Europa Limited (GB) | 2023-07-26 | — | — | EP | claimed |
| CN-112782137-B | Flow cytometer detection method for living plankton living cells with 10-50 mu m | 自然资源部第一海洋研究所 | 2022-10-25 | — | — | CN | claimed |
| CN-115078231-A | Ballast water microalgae microscopic imaging detection equipment and method | 大连环信科技有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2022058758-A1 | DISCONNECTION AGENTS | DC EUROPA LIMITED (GB) | 2022-03-24 | — | — | WO | claimed |
| CN-114134198-A | Reagent, device and method for rapidly counting eukaryotic microorganisms | 国家粮食和物资储备局科学研究院 | 2022-03-04 | — | — | CN | claimed |
| US-20260144810-A1 | mRNA COMPOSITION FOR TREATING CANCER, PREPARATION CONTAINING THE SAME AND USE THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-05-28 | — | — | US | disclosed |
| CN-122094670-A | Novel markers for tumor neoantigen vaccine | — | 2026-05-26 | — | — | CN | disclosed |
| US-12637669-B2 | Two-dimensional and three-dimensional microarray cell cultures using elastomeric assembly substrates | NUTECH VENTURES (US) | 2026-05-26 | — | — | US | disclosed |
| US-12637513-B2 | Method of treating cancer by administering an inhibitor of erythropoietin receptor activity comprising either erythropoietin receptor or erythropoietin protein | IMMUNEDGE, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20220025053-A1 | Methods of Inhibiting Metastasis in Cancer | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2022-01-27 | — | — | US | disclosed |
| WO-2022016270-A1 | FUSION PROTEINS COMPRISING A LIGAND-RECEPTOR PAIR AND A BIOLOGICALLY FUNCTIONAL PROTEIN | ZYMEWORKS INC. (CA) | 2022-01-27 | — | — | WO | disclosed |
| WO-2022020644-A2 | THERAPEUTIC HYDROGEL FOR THE DELIVERY OF CAR-T CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-01-27 | — | — | WO | disclosed |
| EP-3672652-B1 | ARTIFICIAL CARTILAGE AND METHOD FOR ITS PRODUCTION | VETERINAERMEDIZINISCHE UNIV WIEN (AT) | 2022-01-26 | — | — | EP | disclosed |
| EP-3942021-A1 | METHOD OF IMPROVING THE IN VIVO SURVIVAL OF MESENCHYMAL STEM CELLS | The Administrators of The Tulane Educational Fund (US) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637513-B2 | Method of treating cancer by administering an inhibitor of erythropoietin receptor activity comprising either erythropoietin receptor or erythropoietin protein | EPOR, MPL, CSF3R | GSTP1 4066/4885MAPT 4634/4885MEN1 2590/4885 |
| US-12637669-B2 | Two-dimensional and three-dimensional microarray cell cultures using elastomeric assembly substrates | EPCAM, STUB1, MEF2D | GSTP1 4517/4885MAPT 141/4885MEN1 2304/4885 |
| US-20260144810-A1 | mRNA COMPOSITION FOR TREATING CANCER, PREPARATION CONTAINING THE SAME AND USE THEREOF | CD47, IL2RA, IL2 | GSTP1 4568/4885MAPT 2047/4885MEN1 1534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.